Alunbrig vs Lorviqua: Side-by-Side Comparison
Quick answer: Alunbrig and Lorviqua are both alk tyrosine kinase inhibitor used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Alunbrig | Lorviqua |
|---|---|---|
| Drug class | ALK tyrosine kinase inhibitor | ALK tyrosine kinase inhibitor |
| ATC code | L01ED | L01ED05 |
| Primary indications | ALK-positive non-small cell lung cancer | ALK-positive non-small cell lung cancer |
| Mechanism | Selective inhibitor of anaplastic lymphoma kinase (ALK) and ROS1 tyrosine kinases blocking tumor cell proliferation | Third-generation ALK and ROS1 tyrosine kinase inhibitor blocking oncogenic signaling in ALK-rearranged tumors |
| Common dose | 90 mg once daily for 7 days, then 180 mg once daily | 100 mg once daily |
| Detail page | Alunbrig details → | Lorviqua details → |
How to choose between Alunbrig and Lorviqua
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All ALK tyrosine kinase inhibitor on iMedic · Alunbrig full details · Lorviqua full details
Frequently asked questions
Is Alunbrig better than Lorviqua?
Neither is universally 'better.' They are both alk tyrosine kinase inhibitor with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Alunbrig to Lorviqua?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Alunbrig and Lorviqua have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Alunbrig and Lorviqua available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.